Amylyx Pharmaceuticals, Inc.
AMLX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001658551
In the last 90 days, Amylyx Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 6 sales; 206 institutions reported holding it in 13F filings for Q2 2026, worth $2.07B in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Amylyx Pharmaceuticals, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 78 | 95 | +17 |
| Shares | 26.6M | 37.3M | +10.6M (+40.0%) |
| Value | $512.9M | $1.05B | +$532.3M (+103.8%) |
New holders (33)
Institutions that held Amylyx Pharmaceuticals, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (16)
Institutions that held Amylyx Pharmaceuticals, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Tybourne Capital Management (HK) Ltd | 768,603 | $14.8M |
| 683 Capital Management, LLC | 677,714 | $13.0M |
| Ikarian Capital, LLC | 246,554 | $4.75M |
| Sofinnova Investments, Inc. | 187,381 | $3.61M |
| Jane Street Group, LLC | 179,602 | $3.46M |
| Tri Locum Partners LP | 80,459 | $1.55M |
| Artal Group S.A. | 75,000 | $1.45M |
| Virtu Financial LLC | 36,003 | $693.0K |
| Boothbay Fund Management, LLC | 34,500 | $664.0K |
| Picton Mahoney Asset Management | 23,200 | $446.0K |
| HAP Trading, LLC | 15,322 | $295.0K |
| Walleye Trading LLC | 5,525 | $106.0K |
| PEAK6 Investments LLC | 1,500 | $32.4K |
| Glassman Wealth Services | 39 | $1.00K |
| Captrust Financial Advisors | 19 | $0 |
| TCI Wealth Advisors, Inc. | 21 | $0 |